We are live on !
Find out more
Creative Planning Portfolio holdings
AUM
$171B
Turnover
10.62%
1-Year Est. Return
24.68%
This Fund
S&P 500
This Quarter Est. Return
+14.14%
1 Year Est. Return
+24.68%
3 Year Est. Return
+62.17%
5 Year Est. Return
+55.89%
10 Year Est. Return
+171.9%
AUM
$171B
AUM Growth
+$23.7B
(+16%)
Cap. Flow
+$6.93B
Cap. Flow % of AUM
Cap. Flow %
4.05%
Top 10 Holdings %
Top 10 Hldgs %
41.66%
Holding
4,427
New
337
Increased
2,605
Reduced
1,239
Closed
133
Avg Time Held
Equity + Options
4.2
years
Top 10 Avg Time Held
Equity + Options
1.7
years
Top 20 Avg Time Held
Equity + Options
4.3
years
Avg Time Held Equity only
4.3
years
Top 10 Avg Time Held Equity only
1.7
years
Top 20 Avg Time Held Equity only
4.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$682M |
| 2 |
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
|
+$526M |
| 3 |
Vanguard Short-Term Bond ETF
BSV
|
+$504M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$431M |
| 5 |
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$239M |
| 2 |
Vanguard Morningstar Large-Cap ETF
VV
|
+$74.4M |
| 3 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$41.1M |
| 4 |
Honeywell
HON
|
+$39.3M |
| 5 |
iShares Core US Aggregate Bond ETF
AGG
|
+$38.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 73.8% |
| 2 | Technology | 9.57% |
| 3 | Financials | 3.79% |
| 4 | Industrials | 2.49% |
| 5 | Healthcare | 2.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2651
LegalZoom.com
LZ
$1.2B
| $986K | ﹤0.01% |
160,871
+84,994
| +112% | +$521K |
2024 Q3
7 quarters
|
|
2652
CryoPort
CYRX
$911M
| $984K | ﹤0.01% |
62,701
+18,790
| +43% | +$241K |
2025 Q2
4 quarters
|
|
2653
Enliven Therapeutics
ELVN
$3.04B
| $984K | ﹤0.01% |
19,386
+5,714
| +42% | +$243K |
2026 Q1
1 quarter
|
|
2654
John Hancock Multifactor Mid Cap ETF
JHMM
$5.96B
| $983K | ﹤0.01% |
13,110
+2,125
| +19% | +$153K |
2024 Q3
7 quarters
|
|
2655
ProShares Merger ETF
MRGR
$15.9M
| $982K | ﹤0.01% |
21,599
+1,552
| +8% | +$70.1K |
2025 Q3
3 quarters
|
|
2656
Eaton Vance Risk-Managed Diversified Equity Income Fund
ETJ
$532M
| $980K | ﹤0.01% |
118,544
-31,935
| -21% | -$267K |
2025 Q1
5 quarters
|
|
2657
JPMorgan BetaBuilders Europe ETF
BBEU
$8.89B
| $977K | ﹤0.01% |
12,565
-423
| -3% | -$32.5K |
2020 Q3
23 quarters
|
|
2658
Yext
YEXT
$727M
| $977K | ﹤0.01% |
209,222
+164,559
| +368% | +$639K |
2025 Q2
4 quarters
|
|
2659
Federal Agricultural Mortgage
AGM
$2.17B
| $971K | ﹤0.01% |
4,871
+693
| +17% | +$121K |
2021 Q3
19 quarters
|
|
2660
Parsons
PSN
$5.24B
| $970K | ﹤0.01% |
18,522
+5,568
| +43% | +$301K |
2023 Q3
11 quarters
|
|
2661
South Bow Corp
SOBO
$7.39B
| $969K | ﹤0.01% |
27,506
-1
| -0% | -$35 |
2024 Q4
6 quarters
|
|
2662
Capital Group Core Equity ETF
CGUS
$11.9B
| $966K | ﹤0.01% |
21,727
-5,141
| -19% | -$220K |
2023 Q1
13 quarters
|
|
2663
Arcus Biosciences
RCUS
$2.36B
| $966K | ﹤0.01% |
31,342
-2,103
| -6% | -$52K |
2025 Q2
4 quarters
|
|
2664
Orchid Island Capital
ORC
$997M
| $966K | ﹤0.01% |
138,622
+102,099
| +280% | +$704K |
2023 Q4
10 quarters
|
|
2665
Northwest Natural Holdings
NWN
$2.1B
| $966K | ﹤0.01% |
19,681
+3,311
| +20% | +$170K |
2024 Q3
7 quarters
|
|
2666
Quanex
NX
$917M
| $966K | ﹤0.01% |
51,854
-794
| -2% | -$14.7K |
2024 Q4
6 quarters
|
|
2667
NeoGenomics
NEO
$2.13B
| $964K | ﹤0.01% |
66,077
+5,479
| +9% | +$52.9K |
2020 Q3
23 quarters
|
|
2668
AllianzIM U.S. Equity Buffer15 Uncapped Feb ETF
FEBU
$51.5M
| $963K | ﹤0.01% |
32,431
| – | – |
2025 Q2
4 quarters
|
|
2669
ProShares S&P MidCap 400 Dividend Aristocrats ETF
REGL
$1.7B
| $963K | ﹤0.01% |
10,513
-589
| -5% | -$52.6K |
2025 Q3
3 quarters
|
|
2670
Shake Shack
SHAK
$2.63B
| $958K | ﹤0.01% |
17,107
-13,552
| -44% | -$1.02M |
2024 Q1
9 quarters
|
|
2671
CRA International
CRAI
$1.26B
| $957K | ﹤0.01% |
6,722
+1,883
| +39% | +$283K |
2023 Q4
10 quarters
|
|
2672
Grupo Aeroportuario Centro Norte
OMAB
$4.76B
| $955K | ﹤0.01% |
8,445
-422
| -5% | -$45.5K |
2023 Q4
10 quarters
|
|
2673
Rapport Therapeutics
RAPP
$1.24B
| $955K | ﹤0.01% |
22,918
+7,399
| +48% | +$272K |
2025 Q2
4 quarters
|
|
2674
Invesco S&P International Developed Momentum ETF
IDMO
$4.11B
| $955K | ﹤0.01% |
15,832
-2,444
| -13% | -$145K |
2025 Q2
4 quarters
|
|
2675
Vitamin Cottage Natural Grocers
NGVC
$725M
| $954K | ﹤0.01% |
30,770
+16,278
| +112% | +$468K |
2026 Q1
1 quarter
|
|
Similar funds
Creative Planning's Q2 2026 Portfolio in Review
As of Q2 2026, Creative Planning held 4,427 positions worth $171B, up 16% from $147B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Creative Planning deployed $6.93B of net new capital in Q2 2026, opening 337 new positions and adding to 2,605 existing holdings. Its largest new stake was Honeywell Aerospace: 169,880 shares worth $37.6M.
By sector, the portfolio is most concentrated in Miscellaneous at 74% of assets, down from 76% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $239M trimmed.
- Creative Planning's largest Q2 2026 buy was Honeywell Aerospace: 169,880 shares worth $37.6M.
- Creative Planning added most to Vanguard Total Bond Market in Q2 2026, an estimated $682M increase.
- Creative Planning's biggest Q2 2026 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $239M.
- Creative Planning fully exited Hologic in Q2 2026, selling an estimated $8.29M.
- Creative Planning's ten largest holdings make up 42% of its $171B portfolio in Q2 2026.
- Creative Planning opened 337 new positions and closed 133 in Q2 2026.
- Creative Planning's portfolio value rose 16% quarter-over-quarter to $171B.
Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.